{"id":2106,"date":"2025-10-29T08:00:00","date_gmt":"2025-10-29T15:00:00","guid":{"rendered":"https:\/\/phcventures.ca\/?p=2106"},"modified":"2025-10-29T15:03:58","modified_gmt":"2025-10-29T22:03:58","slug":"phc-ventures-ventripoint-ai-cardiac-imaging","status":"publish","type":"post","link":"https:\/\/phcventures.ca\/fr\/phc-ventures-ventripoint-ai-cardiac-imaging\/","title":{"rendered":"Providence Health Care Ventures et Ventripoint s'associent pour valider l'imagerie cardiaque bas\u00e9e sur l'IA \u00e0 l'h\u00f4pital St.\u00a0"},"content":{"rendered":"<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"675\" src=\"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/10\/clinician-using-an-ultrasound-device.jpg\" alt=\"A clinician using an ultrasound device or echocardiography probe on a patient.\" class=\"wp-image-2107\" srcset=\"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/10\/clinician-using-an-ultrasound-device.jpg 1200w, https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/10\/clinician-using-an-ultrasound-device-300x169.jpg 300w, https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/10\/clinician-using-an-ultrasound-device-768x432.jpg 768w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Cette nouvelle collaboration vise \u00e0 r\u00e9duire les temps d'attente pour l'IRM cardiaque et \u00e0 \u00e9largir l'acc\u00e8s aux diagnostics cardiaques avanc\u00e9s dans les communaut\u00e9s urbaines et isol\u00e9es.\u00a0<\/h2>\n\n\n\n<p>Providence Health Care Ventures (PHC Ventures) et <a href=\"https:\/\/ventripoint.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Ventripoint Diagnostics Ltd.<\/a> ont annonc\u00e9 aujourd'hui une collaboration visant \u00e0 valider la technologie VMS+\u2122 de Ventripoint \u00e0 l'h\u00f4pital St. Paul (SPH). L'initiative \u00e9valuera comment l'\u00e9chocardiographie am\u00e9lior\u00e9e par l'intelligence artificielle pourrait r\u00e9duire les longs d\u00e9lais d'attente pour l'IRM en permettant une \u00e9valuation cardiaque pr\u00e9cise plus t\u00f4t dans le processus de diagnostic, ce qui pourrait permettre \u00e0 de nombreux patients d'\u00e9viter compl\u00e8tement l'IRM.&nbsp;<\/p>\n\n\n\n<p>Jusqu'\u00e0 pr\u00e9sent, l'IRM cardiaque \u00e9tait souvent la seule option pour obtenir les mesures cardiaques pr\u00e9cises n\u00e9cessaires pour guider les d\u00e9cisions th\u00e9rapeutiques. VMS+\u2122 utilise l'IA pour g\u00e9n\u00e9rer des mod\u00e8les cardiaques en 3D \u00e0 partir d'images d'\u00e9chocardiographie standard en 2D, fournissant des mesures cardiaques qui correspondent \u00e9troitement \u00e0 celles de l'IRM cardiaque - l'\u00e9talon-or actuel en mati\u00e8re de pr\u00e9cision. La technologie est \u00e0 la fois autoris\u00e9e par la FDA et par Sant\u00e9 Canada, et fonctionne sur l'\u00e9quipement d'\u00e9chographie existant, ce qui permet aux h\u00f4pitaux et aux cliniques d'augmenter leur capacit\u00e9 d'imagerie cardiaque avanc\u00e9e sans avoir \u00e0 acheter de nouveaux scanners.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">S'appuyer sur des r\u00e9sultats cliniques \u00e9prouv\u00e9s\u00a0<\/h2>\n\n\n\n<p>La technologie de Ventripoint a d\u00e9j\u00e0 \u00e9t\u00e9 mise en \u0153uvre au Peter Munk Cardiac Centre (University Health Network, Toronto) et \u00e9valu\u00e9e dans le cadre d'\u00e9tudes cliniques \u00e0 la Mayo Clinic, o\u00f9 elle a d\u00e9montr\u00e9 une concordance clinique entre les mesures cardiaques d\u00e9riv\u00e9es de l'\u00e9chographie et celles d\u00e9riv\u00e9es de l'IRM. Ces \u00e9tudes ont montr\u00e9 qu'il \u00e9tait possible d'obtenir une pr\u00e9cision diagnostique de niveau IRM en utilisant l'\u00e9chocardiographie standard, ce qui am\u00e9liore consid\u00e9rablement l'accessibilit\u00e9 et l'abordabilit\u00e9 de l'imagerie cardiaque avanc\u00e9e.&nbsp;<\/p>\n\n\n\n<p>La collaboration avec PHC Ventures s'appuiera sur ces r\u00e9sultats en validant le VMS+\u2122 dans des flux de travail cliniques r\u00e9els \u00e0 l'h\u00f4pital St. Paul, qui abrite l'un des principaux programmes cardiaques de l'Ouest canadien. Les \u00e9quipes de cardiologie et d'imagerie cardiaque avanc\u00e9e de l'h\u00f4pital St. Paul \u00e9valueront les performances du VMS+\u2122 dans le cadre des protocoles d'\u00e9chocardiographie et d'IRM de routine, en comparant les mesures avec les r\u00e9sultats de l'IRM cardiaque et en \u00e9valuant la pr\u00e9cision, l'int\u00e9gration du flux de travail et l'impact sur le syst\u00e8me de sant\u00e9, notamment la r\u00e9duction potentielle des renvois \u00e0 l'IRM, la diminution des temps d'attente et les \u00e9conomies de co\u00fbts.&nbsp;<\/p>\n\n\n\n<p>\u201cCette technologie permet d'identifier les patients qui ont vraiment besoin d'une IRM et ceux qui peuvent \u00eatre \u00e9valu\u00e9s en toute s\u00e9curit\u00e9 \u00e0 l'aide d'un \u00e9chocardiogramme standard\u201d, a d\u00e9clar\u00e9 Brian Simmers, pr\u00e9sident de PHC Ventures. \u201cCe faisant, nous pouvons r\u00e9duire les temps d'attente pour l'IRM, diminuer les co\u00fbts et fournir un acc\u00e8s plus rapide \u00e0 des soins cardiaques de haute qualit\u00e9.\u201d&nbsp;<\/p>\n\n\n\n<p>\u201c L'IRM reste l'\u00e9talon-or de l'imagerie cardiaque, mais elle n'est pas toujours \u00e0 la port\u00e9e de tous les patients \u201d, explique le Dr Robert Moss, m\u00e9decin responsable de l'\u00e9chocardiographie \u00e0 l'h\u00f4pital St. Paul. \u201c La promesse de l'\u00e9chocardiographie am\u00e9lior\u00e9e par l'IA comme le VMS+\u2122 est qu'elle pourrait apporter une pr\u00e9cision de niveau IRM \u00e0 un outil beaucoup plus accessible. Cela signifie des diagnostics plus rapides, de meilleures d\u00e9cisions th\u00e9rapeutiques et, en fin de compte, de meilleurs r\u00e9sultats pour les patients ; en particulier dans les communaut\u00e9s o\u00f9 l'acc\u00e8s \u00e0 l'imagerie avanc\u00e9e est limit\u00e9.\u201d&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">\u00c9largir l'acc\u00e8s au-del\u00e0 des centres urbains\u00a0<\/h2>\n\n\n\n<p>Parce que le VMS+\u2122 compl\u00e8te les syst\u00e8mes d'\u00e9chographie conventionnels, il a un potentiel important pour apporter des diagnostics cardiaques avanc\u00e9s aux communaut\u00e9s rurales et indig\u00e8nes, o\u00f9 l'acc\u00e8s \u00e0 l'IRM est souvent limit\u00e9 ou n\u00e9cessite des d\u00e9placements sur de longues distances. En permettant une pr\u00e9cision proche de l'IRM sur le lieu de soins, cette approche pourrait r\u00e9duire les transferts inutiles de patients et permettre aux prestataires de soins locaux de surveiller plus efficacement la sant\u00e9 cardiaque, comblant ainsi une lacune critique dans l'acc\u00e8s \u00e9quitable \u00e0 l'imagerie avanc\u00e9e.&nbsp;<\/p>\n\n\n\n<p>\u201cNotre vision est de rendre l'imagerie cardiaque de haute qualit\u00e9 disponible partout o\u00f9 un appareil d'\u00e9cho existe\u201d, a d\u00e9clar\u00e9 Hugh MacNaught, pr\u00e9sident et chef de la direction de Ventripoint. \u201c Le partenariat avec PHC Ventures et l'\u00e9quipe de cardiologie de St. Paul nous permet de mettre en \u0153uvre le VMS+\u2122 dans un cadre de classe mondiale et de d\u00e9montrer son potentiel d'am\u00e9lioration de la prestation de soins cardiaques dans divers environnements de soins de sant\u00e9, allant des grands h\u00f4pitaux urbains aux communaut\u00e9s \u00e9loign\u00e9es \u201d.  La mise en \u0153uvre est destin\u00e9e \u00e0 servir de base \u00e0 une prestation de soins innovante qui promet une imagerie cardiaque rapide, accessible et abordable dans des contextes locaux permettant d'am\u00e9liorer les r\u00e9sultats pour les patients\"&nbsp;<\/p>\n\n\n\n<p>La collaboration devrait d\u00e9buter en novembre 2025 et \u00eatre mise en \u0153uvre au d\u00e9but de l'ann\u00e9e 2026.\u00a0<\/p>\n\n\n\n<p><strong>A propos de Ventripoint Diagnostics Ltd.<\/strong>&nbsp;<\/p>\n\n\n\n<p><strong>Ventripoint<\/strong> d\u00e9veloppe des outils d'imagerie cardiaque pilot\u00e9s par l'IA qui transforment les \u00e9chocardiogrammes 2-D en mesures 3-D, offrant des niveaux de pr\u00e9cision IRM pour les quatre cavit\u00e9s cardiaques. Sa plateforme phare VMS+\u2122 est autoris\u00e9e par la FDA am\u00e9ricaine et homologu\u00e9e par Sant\u00e9 Canada, permettant une \u00e9valuation cardiaque pr\u00e9cise et efficace sans avoir recours \u00e0 des scanners sp\u00e9cialis\u00e9s.\u00a0<\/p>\n\n\n\n<p><br>Plus d'informations : <a href=\"https:\/\/ventripoint.com\/?utm_source=chatgpt.com\" target=\"_blank\" rel=\"noreferrer noopener\">ventripoint.com<\/a>\u00a0<\/p>\n\n\n\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>Une nouvelle collaboration vise \u00e0 r\u00e9duire les temps d'attente en IRM cardiaque et \u00e0 \u00e9largir l'acc\u00e8s aux diagnostics cardiaques avanc\u00e9s dans les communaut\u00e9s urbaines et \u00e9loign\u00e9es Providence Health Care Ventures (PHC Ventures) et Ventripoint Diagnostics Ltd. ont annonc\u00e9 aujourd'hui une collaboration visant \u00e0 valider la technologie VMS+\u2122 de Ventripoint \u00e0 l'h\u00f4pital St. Paul (SPH). L'initiative permettra d'\u00e9valuer comment l'\u00e9chocardiographie am\u00e9lior\u00e9e par l'intelligence artificielle pourrait r\u00e9duire....<\/p>","protected":false},"author":8,"featured_media":2110,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2106","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PHC Ventures and Ventripoint Validate AI Cardiac Imaging<\/title>\n<meta name=\"description\" content=\"PHC Ventures partners with Ventripoint to validate AI-enhanced cardiac imaging at St. Paul\u2019s Hospital, improving access and MRI wait times.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/phcventures.ca\/fr\/phc-ventures-ventripoint-ai-cardiac-imaging\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Validating AI Cardiac Imaging at St. Paul\u2019s Hospital\" \/>\n<meta property=\"og:description\" content=\"PHC Ventures and Ventripoint are partnering to validate VMS+ technology that delivers MRI-level heart measurements from echo, reducing wait times and improving access to care.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/phcventures.ca\/fr\/phc-ventures-ventripoint-ai-cardiac-imaging\/\" \/>\n<meta property=\"og:site_name\" content=\"Providence Health Care Ventures\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-29T15:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-29T22:03:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/10\/Ventripoint-hero-image.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Israel Resendiz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Validating AI Cardiac Imaging at St. Paul\u2019s Hospital\" \/>\n<meta name=\"twitter:description\" content=\"PHC Ventures and Ventripoint are partnering to validate VMS+ technology that delivers MRI-level heart measurements from echo, reducing wait times and improving access to care.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/10\/Ventripoint-hero-image.png\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Israel Resendiz\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/\"},\"author\":{\"name\":\"Israel Resendiz\",\"@id\":\"https:\/\/phcventures.ca\/#\/schema\/person\/c44279ba053e0deec14c02c4f1bdba97\"},\"headline\":\"Providence Health Care Ventures and Ventripoint Partner to Validate AI-Enabled Cardiac Imaging at St. Paul&#8217;s Hospital\u00a0\",\"datePublished\":\"2025-10-29T15:00:00+00:00\",\"dateModified\":\"2025-10-29T22:03:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/\"},\"wordCount\":677,\"publisher\":{\"@id\":\"https:\/\/phcventures.ca\/#organization\"},\"image\":{\"@id\":\"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/10\/Ventripoint-hero-image.png\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"fr-CA\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/\",\"url\":\"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/\",\"name\":\"PHC Ventures and Ventripoint Validate AI Cardiac Imaging\",\"isPartOf\":{\"@id\":\"https:\/\/phcventures.ca\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/10\/Ventripoint-hero-image.png\",\"datePublished\":\"2025-10-29T15:00:00+00:00\",\"dateModified\":\"2025-10-29T22:03:58+00:00\",\"description\":\"PHC Ventures partners with Ventripoint to validate AI-enhanced cardiac imaging at St. Paul\u2019s Hospital, improving access and MRI wait times.\",\"breadcrumb\":{\"@id\":\"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/#primaryimage\",\"url\":\"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/10\/Ventripoint-hero-image.png\",\"contentUrl\":\"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/10\/Ventripoint-hero-image.png\",\"width\":800,\"height\":450},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/phcventures.ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Providence Health Care Ventures and Ventripoint Partner to Validate AI-Enabled Cardiac Imaging at St. Paul&#8217;s Hospital\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/phcventures.ca\/#website\",\"url\":\"https:\/\/phcventures.ca\/\",\"name\":\"Providence Health Care Ventures\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/phcventures.ca\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/phcventures.ca\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/phcventures.ca\/#organization\",\"name\":\"Providence Health Care Ventures\",\"url\":\"https:\/\/phcventures.ca\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/phcventures.ca\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/phcventures.ca\/wp-content\/uploads\/2024\/01\/PHC-Ventures-NoTagline-RGB-1.svg\",\"contentUrl\":\"https:\/\/phcventures.ca\/wp-content\/uploads\/2024\/01\/PHC-Ventures-NoTagline-RGB-1.svg\",\"width\":\"1024\",\"height\":\"1024\",\"caption\":\"Providence Health Care Ventures\"},\"image\":{\"@id\":\"https:\/\/phcventures.ca\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/phcventures.ca\/#\/schema\/person\/c44279ba053e0deec14c02c4f1bdba97\",\"name\":\"Israel Resendiz\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/2c9ce47707fa8f08396b31e5b99c771898bd235916d407beda4cab8fcdcb1090?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2c9ce47707fa8f08396b31e5b99c771898bd235916d407beda4cab8fcdcb1090?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2c9ce47707fa8f08396b31e5b99c771898bd235916d407beda4cab8fcdcb1090?s=96&d=mm&r=g\",\"caption\":\"Israel Resendiz\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PHC Ventures et Ventripoint valident l'imagerie cardiaque par IA","description":"PHC Ventures s'associe \u00e0 Ventripoint pour valider l'imagerie cardiaque am\u00e9lior\u00e9e par l'IA \u00e0 l'h\u00f4pital St. Paul, am\u00e9liorant ainsi l'acc\u00e8s et les temps d'attente pour l'IRM.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/phcventures.ca\/fr\/phc-ventures-ventripoint-ai-cardiac-imaging\/","og_locale":"fr_CA","og_type":"article","og_title":"Validating AI Cardiac Imaging at St. Paul\u2019s Hospital","og_description":"PHC Ventures and Ventripoint are partnering to validate VMS+ technology that delivers MRI-level heart measurements from echo, reducing wait times and improving access to care.","og_url":"https:\/\/phcventures.ca\/fr\/phc-ventures-ventripoint-ai-cardiac-imaging\/","og_site_name":"Providence Health Care Ventures","article_published_time":"2025-10-29T15:00:00+00:00","article_modified_time":"2025-10-29T22:03:58+00:00","og_image":[{"width":800,"height":450,"url":"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/10\/Ventripoint-hero-image.png","type":"image\/png"}],"author":"Israel Resendiz","twitter_card":"summary_large_image","twitter_title":"Validating AI Cardiac Imaging at St. Paul\u2019s Hospital","twitter_description":"PHC Ventures and Ventripoint are partnering to validate VMS+ technology that delivers MRI-level heart measurements from echo, reducing wait times and improving access to care.","twitter_image":"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/10\/Ventripoint-hero-image.png","twitter_misc":{"\u00c9crit par":"Israel Resendiz","Estimation du temps de lecture":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/#article","isPartOf":{"@id":"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/"},"author":{"name":"Israel Resendiz","@id":"https:\/\/phcventures.ca\/#\/schema\/person\/c44279ba053e0deec14c02c4f1bdba97"},"headline":"Providence Health Care Ventures and Ventripoint Partner to Validate AI-Enabled Cardiac Imaging at St. Paul&#8217;s Hospital\u00a0","datePublished":"2025-10-29T15:00:00+00:00","dateModified":"2025-10-29T22:03:58+00:00","mainEntityOfPage":{"@id":"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/"},"wordCount":677,"publisher":{"@id":"https:\/\/phcventures.ca\/#organization"},"image":{"@id":"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/#primaryimage"},"thumbnailUrl":"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/10\/Ventripoint-hero-image.png","articleSection":["Uncategorized"],"inLanguage":"fr-CA"},{"@type":"WebPage","@id":"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/","url":"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/","name":"PHC Ventures et Ventripoint valident l'imagerie cardiaque par IA","isPartOf":{"@id":"https:\/\/phcventures.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/#primaryimage"},"image":{"@id":"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/#primaryimage"},"thumbnailUrl":"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/10\/Ventripoint-hero-image.png","datePublished":"2025-10-29T15:00:00+00:00","dateModified":"2025-10-29T22:03:58+00:00","description":"PHC Ventures s'associe \u00e0 Ventripoint pour valider l'imagerie cardiaque am\u00e9lior\u00e9e par l'IA \u00e0 l'h\u00f4pital St. Paul, am\u00e9liorant ainsi l'acc\u00e8s et les temps d'attente pour l'IRM.","breadcrumb":{"@id":"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/#primaryimage","url":"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/10\/Ventripoint-hero-image.png","contentUrl":"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/10\/Ventripoint-hero-image.png","width":800,"height":450},{"@type":"BreadcrumbList","@id":"https:\/\/phcventures.ca\/phc-ventures-ventripoint-ai-cardiac-imaging\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/phcventures.ca\/"},{"@type":"ListItem","position":2,"name":"Providence Health Care Ventures and Ventripoint Partner to Validate AI-Enabled Cardiac Imaging at St. Paul&#8217;s Hospital\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/phcventures.ca\/#website","url":"https:\/\/phcventures.ca\/","name":"Providence Health Care Ventures","description":"","publisher":{"@id":"https:\/\/phcventures.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/phcventures.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/phcventures.ca\/#organization","name":"Providence Health Care Ventures","url":"https:\/\/phcventures.ca\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/phcventures.ca\/#\/schema\/logo\/image\/","url":"https:\/\/phcventures.ca\/wp-content\/uploads\/2024\/01\/PHC-Ventures-NoTagline-RGB-1.svg","contentUrl":"https:\/\/phcventures.ca\/wp-content\/uploads\/2024\/01\/PHC-Ventures-NoTagline-RGB-1.svg","width":"1024","height":"1024","caption":"Providence Health Care Ventures"},"image":{"@id":"https:\/\/phcventures.ca\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/phcventures.ca\/#\/schema\/person\/c44279ba053e0deec14c02c4f1bdba97","name":"Isra\u00ebl Resendiz","image":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/secure.gravatar.com\/avatar\/2c9ce47707fa8f08396b31e5b99c771898bd235916d407beda4cab8fcdcb1090?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2c9ce47707fa8f08396b31e5b99c771898bd235916d407beda4cab8fcdcb1090?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2c9ce47707fa8f08396b31e5b99c771898bd235916d407beda4cab8fcdcb1090?s=96&d=mm&r=g","caption":"Israel Resendiz"}}]}},"_links":{"self":[{"href":"https:\/\/phcventures.ca\/fr\/wp-json\/wp\/v2\/posts\/2106","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/phcventures.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/phcventures.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/phcventures.ca\/fr\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/phcventures.ca\/fr\/wp-json\/wp\/v2\/comments?post=2106"}],"version-history":[{"count":1,"href":"https:\/\/phcventures.ca\/fr\/wp-json\/wp\/v2\/posts\/2106\/revisions"}],"predecessor-version":[{"id":2108,"href":"https:\/\/phcventures.ca\/fr\/wp-json\/wp\/v2\/posts\/2106\/revisions\/2108"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/phcventures.ca\/fr\/wp-json\/wp\/v2\/media\/2110"}],"wp:attachment":[{"href":"https:\/\/phcventures.ca\/fr\/wp-json\/wp\/v2\/media?parent=2106"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/phcventures.ca\/fr\/wp-json\/wp\/v2\/categories?post=2106"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/phcventures.ca\/fr\/wp-json\/wp\/v2\/tags?post=2106"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}